Status:

COMPLETED

Depression Prevention in Older Spousally-bereaved Adults

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Depression

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

Using an indicated prevention approach, investigators propose to enroll 150 spousally-bereaved adults aged 60 years and older in the first 12 months after spousal death who are at high risk for major ...

Detailed Description

The primary aim of this R01 application is to test the efficacy of a new behavioral intervention that targets the timing and regularity of sleep, meals, and physical activity to stabilize circadian rh...

Eligibility Criteria

Inclusion

  • aged 60 years and older;
  • spousally (or partner) bereaved up to 12 months (includes bereaved as a result of COVID-19);
  • at-risk for major depressive disorder (MDD), based on high-risk markers defined as subthreshold symptoms of depression (Hamilton Depression Rating Scale score of \> or = 9), together with absence of current MDD, post-traumatic stress disorder, or persistent complex bereavement disorder

Exclusion

  • current Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-5) criteria for syndromal mood, psychosis within the last 12 months;
  • dementia/cognitive impairment; Telephone Interview Cognitive Screening (TICS) \<19;
  • acute suicide risk; based on Herbeck et al. protocol for suicide risk management;
  • patients taking new psychotropic medications after spousal death to stabilize depression including antidepressants and benzodiazepines \>4 days/week for more than two months. Individuals who have been on a stable dose for at least 1 month and agree not to change during participation, unless it is medically necessary, will be included.

Key Trial Info

Start Date :

October 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 17 2025

Estimated Enrollment :

151 Patients enrolled

Trial Details

Trial ID

NCT04016896

Start Date

October 20 2020

End Date

January 17 2025

Last Update

December 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UPMC: WPIC- Bellefield Towers

Pittsburgh, Pennsylvania, United States, 15213